Hemostatic imbalance induced by tamoxifen in estrogen receptor-positive breast cancer patients: An observational study.

This observational study showed that patients in remission from ER+ breast cancer taking tamoxifen had altered thrombin generation, as well as an acquired APC resistance. Moreover, this is the first study using the validated ETP-based APC resistance assay in tamoxifen-treated patients.